These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26515212)

  • 1. Acute Stroke: Shifting From Informed Consent to Informed Refusal of Intravenous Tissue-Type Plasminogen Activator.
    Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2015 Oct; 8(6 Suppl 3):S69-72. PubMed ID: 26515212
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Centered Decision Support in Acute Ischemic Stroke: Qualitative Study of Patients' and Providers' Perspectives.
    Decker C; Chhatriwalla E; Gialde E; Garavalia B; Summers D; Quinlan ME; Cheng E; Rymer M; Saver JL; Chen E; Kent DM; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2015 Oct; 8(6 Suppl 3):S109-16. PubMed ID: 26515198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
    Leppert MH; Campbell JD; Simpson JR; Burke JF
    Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice.
    Rosenbaum JR; Bravata DM; Concato J; Brass LM; Kim N; Fried TR
    Stroke; 2004 Sep; 35(9):e353-5. PubMed ID: 15243145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke.
    Kufner A; Nolte CH; Galinovic I; Brunecker P; Kufner GM; Endres M; Fiebach JB; Ebinger M
    Stroke; 2013 Feb; 44(2):407-13. PubMed ID: 23287785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
    Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Alberts MJ
    Circulation; 2017 Jan; 135(2):140-142. PubMed ID: 28069710
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Plas et al regarding article, "smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke".
    Plas GJ; Uyttenboogaart M; Luijckx GJ
    Stroke; 2013 May; 44(5):e58. PubMed ID: 23559266
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.
    Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients and intra-arterial stroke therapy.
    Leslie-Mazwi TM; Chandra RV; Simonsen CZ; Yoo AJ
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1713-23. PubMed ID: 24195443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke.
    Berkowitz AL; Mittal MK; McLane HC; Shen GC; Muralidharan R; Lyons JL; Shinohara RT; Shuaib A; Mateen FJ
    Int J Stroke; 2014 Apr; 9(3):349-55. PubMed ID: 24207029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Decision Making: Hyposphagma Prior to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
    Newey CR; Cueva W; Vellipuram A; Hornik A
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e181-2. PubMed ID: 27492945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke--a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia.
    Ad Hoc Committee representing the National Stroke Foundation and the Stroke Society of Australasia
    Intern Med J; 2009 May; 39(5):317-24. PubMed ID: 19545242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.